ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Loxoprofen Sodium Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-32K16811
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Oral Loxoprofen Sodium Market Research Report 2024
BUY CHAPTERS

Global Oral Loxoprofen Sodium Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-32K16811
Report
November 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Disha Pharmaceutical
Jiudian Pharmaceutical
Chongqing Kerui Pharmaceutical
Ningbo Liwah Pharmaceutical
Dawnrays Pharmaceutical

Oral Loxoprofen Sodium Market

The global Oral Loxoprofen Sodium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital and Clinic accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Oral Loxoprofen Sodium leading manufacturers including Daiichi Sankyo, Eisai, Disha Pharmaceutical, Jiudian Pharmaceutical, Chongqing Kerui Pharmaceutical, Ningbo Liwah Pharmaceutical, Dawnrays Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Daiichi Sankyo leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Oral Loxoprofen Sodium market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Oral Loxoprofen Sodium Market Report

Report Metric Details
Report Name Oral Loxoprofen Sodium Market
Segment by Type
  • Original Drug
  • Generic Drug
Segment by Application
  • Hospital and Clinic
  • Pharmacy
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Daiichi Sankyo, Eisai, Disha Pharmaceutical, Jiudian Pharmaceutical, Chongqing Kerui Pharmaceutical, Ningbo Liwah Pharmaceutical, Dawnrays Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Oral Loxoprofen Sodium study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Oral Loxoprofen Sodium Market report?

Ans: The main players in the Oral Loxoprofen Sodium Market are Daiichi Sankyo, Eisai, Disha Pharmaceutical, Jiudian Pharmaceutical, Chongqing Kerui Pharmaceutical, Ningbo Liwah Pharmaceutical, Dawnrays Pharmaceutical

What are the Application segmentation covered in the Oral Loxoprofen Sodium Market report?

Ans: The Applications covered in the Oral Loxoprofen Sodium Market report are Hospital and Clinic, Pharmacy

What are the Type segmentation covered in the Oral Loxoprofen Sodium Market report?

Ans: The Types covered in the Oral Loxoprofen Sodium Market report are Original Drug, Generic Drug

1 Study Coverage
1.1 Introduction to Oral Loxoprofen Sodium: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Oral Loxoprofen Sodium Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market Segmentation by Application
1.3.1 Global Oral Loxoprofen Sodium Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oral Loxoprofen Sodium Revenue Estimates and Forecasts 2020-2031
2.2 Global Oral Loxoprofen Sodium Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Oral Loxoprofen Sodium Sales Estimates and Forecasts 2020-2031
2.4 Global Oral Loxoprofen Sodium Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Oral Loxoprofen Sodium Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Oral Loxoprofen Sodium Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Original Drug Market Size by Manufacturers
3.5.2 Generic Drug Market Size by Manufacturers
3.6 Global Oral Loxoprofen Sodium Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Oral Loxoprofen Sodium Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Oral Loxoprofen Sodium Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Oral Loxoprofen Sodium Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Oral Loxoprofen Sodium Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Oral Loxoprofen Sodium Sales and Revenue by Type (2020-2031)
6.4 North America Oral Loxoprofen Sodium Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Oral Loxoprofen Sodium Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Oral Loxoprofen Sodium Sales and Revenue by Type (2020-2031)
7.4 Europe Oral Loxoprofen Sodium Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Oral Loxoprofen Sodium Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Oral Loxoprofen Sodium Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Oral Loxoprofen Sodium Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Oral Loxoprofen Sodium Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Oral Loxoprofen Sodium Sales and Revenue by Type (2020-2031)
9.4 Central and South America Oral Loxoprofen Sodium Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Oral Loxoprofen Sodium Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Oral Loxoprofen Sodium Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Oral Loxoprofen Sodium Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Oral Loxoprofen Sodium Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Daiichi Sankyo
11.1.1 Daiichi Sankyo Corporation Information
11.1.2 Daiichi Sankyo Business Overview
11.1.3 Daiichi Sankyo Oral Loxoprofen Sodium Product Models, Descriptions and Specifications
11.1.4 Daiichi Sankyo Oral Loxoprofen Sodium Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Daiichi Sankyo Oral Loxoprofen Sodium Sales by Product in 2024
11.1.6 Daiichi Sankyo Oral Loxoprofen Sodium Sales by Application in 2024
11.1.7 Daiichi Sankyo Oral Loxoprofen Sodium Sales by Geographic Area in 2024
11.1.8 Daiichi Sankyo Oral Loxoprofen Sodium SWOT Analysis
11.1.9 Daiichi Sankyo Recent Developments
11.2 Eisai
11.2.1 Eisai Corporation Information
11.2.2 Eisai Business Overview
11.2.3 Eisai Oral Loxoprofen Sodium Product Models, Descriptions and Specifications
11.2.4 Eisai Oral Loxoprofen Sodium Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Eisai Oral Loxoprofen Sodium Sales by Product in 2024
11.2.6 Eisai Oral Loxoprofen Sodium Sales by Application in 2024
11.2.7 Eisai Oral Loxoprofen Sodium Sales by Geographic Area in 2024
11.2.8 Eisai Oral Loxoprofen Sodium SWOT Analysis
11.2.9 Eisai Recent Developments
11.3 Disha Pharmaceutical
11.3.1 Disha Pharmaceutical Corporation Information
11.3.2 Disha Pharmaceutical Business Overview
11.3.3 Disha Pharmaceutical Oral Loxoprofen Sodium Product Models, Descriptions and Specifications
11.3.4 Disha Pharmaceutical Oral Loxoprofen Sodium Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Disha Pharmaceutical Oral Loxoprofen Sodium Sales by Product in 2024
11.3.6 Disha Pharmaceutical Oral Loxoprofen Sodium Sales by Application in 2024
11.3.7 Disha Pharmaceutical Oral Loxoprofen Sodium Sales by Geographic Area in 2024
11.3.8 Disha Pharmaceutical Oral Loxoprofen Sodium SWOT Analysis
11.3.9 Disha Pharmaceutical Recent Developments
11.4 Jiudian Pharmaceutical
11.4.1 Jiudian Pharmaceutical Corporation Information
11.4.2 Jiudian Pharmaceutical Business Overview
11.4.3 Jiudian Pharmaceutical Oral Loxoprofen Sodium Product Models, Descriptions and Specifications
11.4.4 Jiudian Pharmaceutical Oral Loxoprofen Sodium Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Jiudian Pharmaceutical Oral Loxoprofen Sodium Sales by Product in 2024
11.4.6 Jiudian Pharmaceutical Oral Loxoprofen Sodium Sales by Application in 2024
11.4.7 Jiudian Pharmaceutical Oral Loxoprofen Sodium Sales by Geographic Area in 2024
11.4.8 Jiudian Pharmaceutical Oral Loxoprofen Sodium SWOT Analysis
11.4.9 Jiudian Pharmaceutical Recent Developments
11.5 Chongqing Kerui Pharmaceutical
11.5.1 Chongqing Kerui Pharmaceutical Corporation Information
11.5.2 Chongqing Kerui Pharmaceutical Business Overview
11.5.3 Chongqing Kerui Pharmaceutical Oral Loxoprofen Sodium Product Models, Descriptions and Specifications
11.5.4 Chongqing Kerui Pharmaceutical Oral Loxoprofen Sodium Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Chongqing Kerui Pharmaceutical Oral Loxoprofen Sodium Sales by Product in 2024
11.5.6 Chongqing Kerui Pharmaceutical Oral Loxoprofen Sodium Sales by Application in 2024
11.5.7 Chongqing Kerui Pharmaceutical Oral Loxoprofen Sodium Sales by Geographic Area in 2024
11.5.8 Chongqing Kerui Pharmaceutical Oral Loxoprofen Sodium SWOT Analysis
11.5.9 Chongqing Kerui Pharmaceutical Recent Developments
11.6 Ningbo Liwah Pharmaceutical
11.6.1 Ningbo Liwah Pharmaceutical Corporation Information
11.6.2 Ningbo Liwah Pharmaceutical Business Overview
11.6.3 Ningbo Liwah Pharmaceutical Oral Loxoprofen Sodium Product Models, Descriptions and Specifications
11.6.4 Ningbo Liwah Pharmaceutical Oral Loxoprofen Sodium Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Ningbo Liwah Pharmaceutical Recent Developments
11.7 Dawnrays Pharmaceutical
11.7.1 Dawnrays Pharmaceutical Corporation Information
11.7.2 Dawnrays Pharmaceutical Business Overview
11.7.3 Dawnrays Pharmaceutical Oral Loxoprofen Sodium Product Models, Descriptions and Specifications
11.7.4 Dawnrays Pharmaceutical Oral Loxoprofen Sodium Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Dawnrays Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Oral Loxoprofen Sodium Industry Chain
12.2 Oral Loxoprofen Sodium Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Oral Loxoprofen Sodium Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Oral Loxoprofen Sodium Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Oral Loxoprofen Sodium Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Oral Loxoprofen Sodium Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Disha Pharmaceutical
Jiudian Pharmaceutical
Chongqing Kerui Pharmaceutical
Ningbo Liwah Pharmaceutical
Dawnrays Pharmaceutical
List of Tables
 Table 1. Global Oral Loxoprofen Sodium Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Oral Loxoprofen Sodium Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Oral Loxoprofen Sodium Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Oral Loxoprofen Sodium Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Oral Loxoprofen Sodium Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Oral Loxoprofen Sodium Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Oral Loxoprofen Sodium Sales by Region (2020-2025) & (K Units)
 Table 8. Global Oral Loxoprofen Sodium Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Oral Loxoprofen Sodium Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Oral Loxoprofen Sodium Sales Share by Manufacturers (2020-2025)
 Table 12. Global Oral Loxoprofen Sodium Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Oral Loxoprofen Sodium Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Oral Loxoprofen Sodium by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Loxoprofen Sodium as of 2024)
 Table 16. Global Oral Loxoprofen Sodium Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Oral Loxoprofen Sodium Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Oral Loxoprofen Sodium Manufacturing Base and Headquarters
 Table 19. Global Oral Loxoprofen Sodium Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Oral Loxoprofen Sodium Sales by Type (2020-2025) & (K Units)
 Table 23. Global Oral Loxoprofen Sodium Sales by Type (2026-2031) & (K Units)
 Table 24. Global Oral Loxoprofen Sodium Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Oral Loxoprofen Sodium Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Oral Loxoprofen Sodium ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Oral Loxoprofen Sodium Sales by Application (2020-2025) & (K Units)
 Table 29. Global Oral Loxoprofen Sodium Sales by Application (2026-2031) & (K Units)
 Table 30. Oral Loxoprofen Sodium High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Oral Loxoprofen Sodium Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Oral Loxoprofen Sodium Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Oral Loxoprofen Sodium ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Oral Loxoprofen Sodium Growth Accelerators and Market Barriers
 Table 37. North America Oral Loxoprofen Sodium Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Oral Loxoprofen Sodium Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Oral Loxoprofen Sodium Growth Accelerators and Market Barriers
 Table 40. Europe Oral Loxoprofen Sodium Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Oral Loxoprofen Sodium Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Oral Loxoprofen Sodium Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Oral Loxoprofen Sodium Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Oral Loxoprofen Sodium Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Oral Loxoprofen Sodium Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Oral Loxoprofen Sodium Investment Opportunities and Key Challenges
 Table 47. Central and South America Oral Loxoprofen Sodium Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Oral Loxoprofen Sodium Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Oral Loxoprofen Sodium Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Daiichi Sankyo Corporation Information
 Table 51. Daiichi Sankyo Description and Major Businesses
 Table 52. Daiichi Sankyo Product Models, Descriptions and Specifications
 Table 53. Daiichi Sankyo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Daiichi Sankyo Sales Value Proportion by Product in 2024
 Table 55. Daiichi Sankyo Sales Value Proportion by Application in 2024
 Table 56. Daiichi Sankyo Sales Value Proportion by Geographic Area in 2024
 Table 57. Daiichi Sankyo Oral Loxoprofen Sodium SWOT Analysis
 Table 58. Daiichi Sankyo Recent Developments
 Table 59. Eisai Corporation Information
 Table 60. Eisai Description and Major Businesses
 Table 61. Eisai Product Models, Descriptions and Specifications
 Table 62. Eisai Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Eisai Sales Value Proportion by Product in 2024
 Table 64. Eisai Sales Value Proportion by Application in 2024
 Table 65. Eisai Sales Value Proportion by Geographic Area in 2024
 Table 66. Eisai Oral Loxoprofen Sodium SWOT Analysis
 Table 67. Eisai Recent Developments
 Table 68. Disha Pharmaceutical Corporation Information
 Table 69. Disha Pharmaceutical Description and Major Businesses
 Table 70. Disha Pharmaceutical Product Models, Descriptions and Specifications
 Table 71. Disha Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Disha Pharmaceutical Sales Value Proportion by Product in 2024
 Table 73. Disha Pharmaceutical Sales Value Proportion by Application in 2024
 Table 74. Disha Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 75. Disha Pharmaceutical Oral Loxoprofen Sodium SWOT Analysis
 Table 76. Disha Pharmaceutical Recent Developments
 Table 77. Jiudian Pharmaceutical Corporation Information
 Table 78. Jiudian Pharmaceutical Description and Major Businesses
 Table 79. Jiudian Pharmaceutical Product Models, Descriptions and Specifications
 Table 80. Jiudian Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Jiudian Pharmaceutical Sales Value Proportion by Product in 2024
 Table 82. Jiudian Pharmaceutical Sales Value Proportion by Application in 2024
 Table 83. Jiudian Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 84. Jiudian Pharmaceutical Oral Loxoprofen Sodium SWOT Analysis
 Table 85. Jiudian Pharmaceutical Recent Developments
 Table 86. Chongqing Kerui Pharmaceutical Corporation Information
 Table 87. Chongqing Kerui Pharmaceutical Description and Major Businesses
 Table 88. Chongqing Kerui Pharmaceutical Product Models, Descriptions and Specifications
 Table 89. Chongqing Kerui Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Chongqing Kerui Pharmaceutical Sales Value Proportion by Product in 2024
 Table 91. Chongqing Kerui Pharmaceutical Sales Value Proportion by Application in 2024
 Table 92. Chongqing Kerui Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 93. Chongqing Kerui Pharmaceutical Oral Loxoprofen Sodium SWOT Analysis
 Table 94. Chongqing Kerui Pharmaceutical Recent Developments
 Table 95. Ningbo Liwah Pharmaceutical Corporation Information
 Table 96. Ningbo Liwah Pharmaceutical Description and Major Businesses
 Table 97. Ningbo Liwah Pharmaceutical Product Models, Descriptions and Specifications
 Table 98. Ningbo Liwah Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Ningbo Liwah Pharmaceutical Recent Developments
 Table 100. Dawnrays Pharmaceutical Corporation Information
 Table 101. Dawnrays Pharmaceutical Description and Major Businesses
 Table 102. Dawnrays Pharmaceutical Product Models, Descriptions and Specifications
 Table 103. Dawnrays Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Dawnrays Pharmaceutical Recent Developments
 Table 105. Key Raw Materials Distribution
 Table 106. Raw Materials Key Suppliers
 Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 108. Milestones in Production Technology Evolution
 Table 109. Distributors List
 Table 110. Market Trends and Market Evolution
 Table 111. Market Drivers and Opportunities
 Table 112. Market Challenges, Risks, and Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Oral Loxoprofen Sodium Product Picture
 Figure 2. Global Oral Loxoprofen Sodium Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Original Drug Product Picture
 Figure 4. Generic Drug Product Picture
 Figure 5. Global Oral Loxoprofen Sodium Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital and Clinic
 Figure 7. Pharmacy
 Figure 8. Oral Loxoprofen Sodium Report Years Considered
 Figure 9. Global Oral Loxoprofen Sodium Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Oral Loxoprofen Sodium Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Oral Loxoprofen Sodium Revenue Market Share by Region (2020-2031)
 Figure 13. Global Oral Loxoprofen Sodium Sales (2020-2031) & (K Units)
 Figure 14. Global Oral Loxoprofen Sodium Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 15. Global Oral Loxoprofen Sodium Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Oral Loxoprofen Sodium Sales Volume Market Share in 2024
 Figure 17. Global Oral Loxoprofen Sodium Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Original Drug Revenue Market Share by Manufacturer in 2024
 Figure 20. Generic Drug Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Oral Loxoprofen Sodium Sales Market Share by Type (2020-2031)
 Figure 22. Global Oral Loxoprofen Sodium Revenue Market Share by Type (2020-2031)
 Figure 23. Global Oral Loxoprofen Sodium Sales Market Share by Application (2020-2031)
 Figure 24. Global Oral Loxoprofen Sodium Revenue Market Share by Application (2020-2031)
 Figure 25. North America Oral Loxoprofen Sodium Sales YoY (2020-2031) & (K Units)
 Figure 26. North America Oral Loxoprofen Sodium Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Oral Loxoprofen Sodium Sales Revenue (US$ Million) in 2024
 Figure 28. North America Oral Loxoprofen Sodium Sales Volume (K Units) by Type (2020- 2031)
 Figure 29. North America Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Oral Loxoprofen Sodium Sales Volume (K Units) by Application (2020-2031)
 Figure 31. North America Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Oral Loxoprofen Sodium Sales YoY (2020-2031) & (K Units)
 Figure 36. Europe Oral Loxoprofen Sodium Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Oral Loxoprofen Sodium Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Oral Loxoprofen Sodium Sales Volume (K Units) by Type (2020-2031)
 Figure 39. Europe Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Oral Loxoprofen Sodium Sales Volume (K Units) by Application (2020-2031)
 Figure 41. Europe Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 43. France Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Oral Loxoprofen Sodium Sales YoY (2020-2031) & (K Units)
 Figure 48. Asia-Pacific Oral Loxoprofen Sodium Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Oral Loxoprofen Sodium Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Oral Loxoprofen Sodium Sales Volume (K Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Oral Loxoprofen Sodium Sales Volume (K Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 58. India Oral Loxoprofen Sodium Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Oral Loxoprofen Sodium Sales YoY (2020-2031) & (K Units)
 Figure 60. Central and South America Oral Loxoprofen Sodium Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Oral Loxoprofen Sodium Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Oral Loxoprofen Sodium Sales Volume (K Units) by Type (2021-2031)
 Figure 63. Central and South America Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Oral Loxoprofen Sodium Sales Volume (K Units) by Application (2020-2031)
 Figure 65. Central and South America Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Oral Loxoprofen Sodium Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Oral Loxoprofen Sodium Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Oral Loxoprofen Sodium Sales YoY (2020-2031) & (K Units)
 Figure 69. Middle East and Africa Oral Loxoprofen Sodium Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Oral Loxoprofen Sodium Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Oral Loxoprofen Sodium Sales Volume (K Units) by Type (2021-2031)
 Figure 72. South America Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Oral Loxoprofen Sodium Sales Volume (K Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Oral Loxoprofen Sodium Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Oral Loxoprofen Sodium Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Oral Loxoprofen Sodium Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Oral Loxoprofen Sodium Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Oral Loxoprofen Sodium Revenue (2020-2025) & (US$ Million)
 Figure 79. Oral Loxoprofen Sodium Industry Chain Mapping
 Figure 80. Regional Oral Loxoprofen Sodium Manufacturing Base Distribution (%)
 Figure 81. Global Oral Loxoprofen Sodium Production Market Share by Region (2020-2031)
 Figure 82. Oral Loxoprofen Sodium Production Process
 Figure 83. Regional Oral Loxoprofen Sodium Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Loxoprofen Sodium Tablets Market Research Report 2024
Global Loxoprofen Sodium Capsules Market Research Report 2024
Global Naproxen Sodium Market Research Report 2024
Global Loxoprofen Sodium Market Research Report 2024
Global Reagent Grade Ibuprofen Sodium Market Research Report 2025
Global Ibuprofen Sodium API Market Research Report 2025
Global Oxacillin Sodium for Injection Market Research Report 2024
Global Alendronate Sodium Tablets Market Research Report 2024
Global Sugammadex Sodium Market Research Report 2025
Global Cloprostenol Sodium Market Research Report 2025
Global Elagolix Sodium Market Research Report 2025
Global Sodium Fluoride Market Research Report 2024
Global Loxoprofen Sodium Patches Market Research Report 2024
Global Amoxicillin Sodium Market Research Report 2025
Global Enoxaparin Sodium For Injection Market Research Report 2025
Global Flurbiprofen Market Research Report 2024
Global Dalteparin Sodium Market Research Report 2025
Global Fluvastatin Sodium Capsules Market Research Report 2024
Global Enoxaparin Sodium Injection Market Research Report 2024
Global Cephapirin Sodium Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions